Detalhe da pesquisa
1.
Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
Oncologist
; 29(4): e487-e497, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874924
2.
Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma.
J Cell Mol Med
; 27(7): 1006-1020, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919714
3.
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients.
Cancer
; 129(4): 569-579, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541017
4.
MNK2 governs the macrophage antiinflammatory phenotype.
Proc Natl Acad Sci U S A
; 117(44): 27556-27565, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077599
5.
Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
Ann Surg Oncol
; 29(3): 2016-2029, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637058
6.
ASO Author Reflections: Neoadjuvant Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin Is an Incredible Helper in Curing Patients with Intermediate-Advanced-Stage and Technically Resectable Hepatocellular Carcinoma.
Ann Surg Oncol
; 29(3): 2030-2031, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739640
7.
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.
J Hepatocell Carcinoma
; 11: 463-475, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463545
8.
Change of indocyanine green clearance ability and liver function after transcatheter intra-arterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study.
Int J Surg
; 110(5): 2832-2844, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363991
9.
The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
Front Immunol
; 15: 1310239, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711515
10.
The emerging therapies are reshaping the first-line treatment for advanced hepatocellular carcinoma: a systematic review and network meta-analysis.
Therap Adv Gastroenterol
; 17: 17562848241237631, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38645513
11.
Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study.
Sci Rep
; 14(1): 9745, 2024 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679630
12.
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 1157-1167, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497428
13.
Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma.
Int Immunopharmacol
; 115: 109687, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36628893
14.
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study.
J Cancer Res Clin Oncol
; 149(6): 2491-2500, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752744
15.
Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study.
J Cancer Res Clin Oncol
; 149(16): 14761-14774, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589925
16.
Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy.
J Hepatocell Carcinoma
; 10: 2133-2145, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058386
17.
Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma.
Front Pharmacol
; 14: 1210835, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37456741
18.
Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma.
Front Pharmacol
; 14: 1234342, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731737
19.
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy.
J Hepatocell Carcinoma
; 10: 2117-2132, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38053944
20.
Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients.
Int Immunopharmacol
; 115: 109651, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638663